文献速递功能神经外科

乙状窦后入路甘油注射神经根毁损术治疗无明确动脉压迫的三叉神经痛:更新病例系列

Retrosigmoid approach for glycerin rhizotomy in the treatment of trigeminal neuralgia without overt arterial compression: updated case series.
PubMed 文献 · J Neurosurg · 2019-03-08

该回顾性病例系列纳入74例术中未见明确动脉压迫的三叉神经痛患者,在乙状窦后入路下向三叉神经池段下三分之一注射甘油,并与同一术者完成的476例标准微血管减压术患者比较。术后Barron神经病学研究所疼痛评分从术前4.1±0.4改善至术后2.1±1.2,95.9%患者疼痛改善,13例(17.6%)出现术后烧灼痛,5例(6.7%)出现并发症且均为轻微。作者认为该技术总体安全且可能有效。

要点

  • 74例无明确动脉压迫的三叉神经痛患者行乙状窦后入路甘油神经根毁损术。
  • 术后Barron疼痛评分从4.1±0.4改善至2.1±1.2,95.9%患者疼痛改善。
  • 13例(17.6%)出现术后烧灼痛,5例(6.7%)出现轻微并发症。

核心结论

  • 术中向三叉神经注射甘油对于术中未见明确动脉压迫或减压不充分的三叉神经痛患者总体安全且可能有效。

研究设计与样本

  • 回顾性分析74例术中向三叉神经池段下三分之一直接注射甘油的患者,其中14例来自作者先前研究,并与同一术者完成的476例标准微血管减压术患者进行比较。

主要发现

  • 74例患者平均随访19.1±18.0个月,男女比为1:2.9。
  • 33例(44.6%)患者既往三叉神经痛干预失败。
  • Barron神经病学研究所疼痛评分从术前4.1±0.4改善至术后2.1±1.2。
  • 95.9%患者术后疼痛改善。
  • 13例(17.6%)出现术后烧灼痛;5例(6.7%)出现并发症,包括切口感染、面瘫、脑脊液漏和听力减退,均为轻微。

临床怎么用

  • 对于术中未见明确动脉压迫或减压不充分的三叉神经痛患者,可考虑术中向三叉神经池段下三分之一注射甘油。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Trigeminal neuralgia (TN) is a neuropathic pain disorder characterized by severe, lancinating facial pain that is commonly treated with neuropathic medication, percutaneous rhizotomy, and/or microvascular decompression (MVD). Patients who are not found to have distinct arterial compression during MVD present a management challenge. In 2013, the authors reported on a small case series of such patients in whom glycerin was injected intraoperatively into the cisternal segment of the trigeminal nerve. The objective of the authors' present study was to report their updated experience with this technique to further validate this novel approach. METHODS: The authors performed a retrospective analysis of data obtained in patients in whom glycerin was directly injected into the inferior third of the cisternal portion of the trigeminal nerve. Seventy-four patients, including 14 patients from the authors' prior study, were identified, and demographic information, intraoperative findings, postoperative course, and complications were recorded. Fisher's exact test, unpaired t-tests, and Kaplan-Meier survival curves using Mantel log-rank test were used to compare the 74 patients with a cohort of 476 patients who received standard MVD by the same surgeon. RESULTS: The 74 patients who underwent MVD and glycerin injection had an average follow-up of 19.1 ± 18.0 months, and the male/female ratio was 1:2.9. In 33 patients (44.6%), a previous intervention for TN had failed. On average, patients had an improvement in the Barrow Neurological Institute Pain Intensity score from 4.1 ± 0.4 before surgery to 2.1 ± 1.2 after surgery. Pain improvement after the surgery was documented in 95.9% of patients. Thirteen patients (17.6%) developed burning pain following surgery. Five patients developed complications (6.7%), including incisional infection, facial palsy, CSF leak, and hearing deficit, all of which were minor. CONCLUSIONS: Intraoperative injection of glycerin into the trigeminal nerve is a generally safe and potentially effective treatment for TN when no distinct site of arterial compression is identified during surgery or when decompression of the nerve is deemed to be inadequate.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kim TY, Jackson CM, Xia Y, et al. Retrosigmoid approach for glycerin rhizotomy in the treatment of trigeminal neuralgia without overt arterial compression: updated case series. J Neurosurg. 2019. PMID: 30849763. doi:10.3171/2018.12.JNS182572

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。